SEC Form 3 · accession 0001140361-19-003423
BALCHEM CORP · BALCHEM CO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott C Mason
Officer — Vice President
Period of report
Feb 13, 2019
Accepted (ET)
Feb 19, 2019 · 1:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000009326
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 214 | D | ||
| Common StockF2 | holding | — | — | — | 8,474 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F3 | $74.57 | holding | — | — | — | Feb 13, 2019 | Feb 23, 2028 | Common Stock | 4,700 | — | D |
| Employee Stock Option (right to buy)F3 | $84.09 | holding | — | — | — | Feb 13, 2020 | Feb 15, 2029 | Common Stock | 5,000 | — | D |
Explanation of responses
- F1Ownership consists of 214 shares held in Reporting Person's Company 401(k)/profit sharing plan account.
- F2Ownership of restricted stock vests in Reporting Person 3 years following the grant dates and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person.
- F3Options vest 20% year 1; 40% year 2; and 40% year 3